{"nct_id":"NCT04524689","title":"Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC","status":"TERMINATED","status_verified_date":"2025-03","start_date":"2020-10-26","start_date_type":"ACTUAL","primary_completion_date":"2024-03-12","primary_completion_date_type":"ACTUAL","completion_date":"2024-12-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}